Inhibitory effect of a novel water-soluble vitamin E derivative on atherosclerosis in rabbits

Atherosclerosis

Volumn 162, Issue 1, 2002, Pages 111-117

  Yoshida, Norimasa ^a   Murase, Hironobu ^b   Kunieda, Tsutomu ^b   Toyokuni, Shinya ^c   Tanaka, Tomoyuki ^c   Terao, Junji ^d   Naito, Yuji ^a   Tanigawa, Toru ^a   Yoshikawa, Toshikazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b CCI Corporation   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Antioxidant; Atherosclerosis; Cholesterol loaded rabbit; Watanabe heritable hyperlipidemic (WHHL) rabbit; Water soluble vitamin E derivative

Indexed keywords

2 (ALPHA DEXTRO GLUCOPYRANOSYL)METHYL 2,5,7,8 TETRAMETHYLCHROMAN 6 OL; ALPHA TOCOPHEROL DERIVATIVE; CHOLESTEROL; DRUG METABOLITE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ATHEROSCLEROSIS; ARTICLE; BLOOD LEVEL; CHOLECYSTOKININ BLOOD LEVEL; CIRCULATION; CONTROLLED STUDY; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SOLUBILITY; DRUG TRANSPORT; HYPERLIPIDEMIA; LIPID PEROXIDATION; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; AORTA; ARTERIOSCLEROSIS; ASPARTATE AMINOTRANSFERASES; BODY WEIGHT; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHROMANS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLYCOSIDES; L-LACTATE DEHYDROGENASE; LIPID METABOLISM; LIPID PEROXIDATION; MALE; MODELS, CARDIOVASCULAR; OXIDATION-REDUCTION; PROBUCOL; RABBITS; SOLUBILITY; VITAMIN E;

EID: 0036228040     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00702-X     Document Type: Article

References (30)

1. Role of oxidized LDL and antioxidant in athrosclerosis
2. Role of oxidized low density lipoprotein in atherogenesis
3. Inverse correlation between plasma vitamin E and mortality from ischemia heart disease in cross-cultural epidemiology
4. Randomised controlled trial of vitamin E in patients with Coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
5. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-prevention trial
6. Vitamin E supplementation and cardiovascular events in high-risk patients
7. Effect of vitamin E on the development of atherosclerosis
8. Effect of antioxidant vitamin E as a protective factor in experimental atherosclerosis in rhesus monkeys
9. Is there a potential therapeutic role for vitamin E or other antioxidants in atherosclerosis?
10. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia
11. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: Evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit
12. Lowering of HDL2b by probucol partly explains the failure of the drug to affect femoral atherosclerosis in subjects with hypercholesterolemia. A Probucol Quantitative Regression Swedish Trial (PQRST) Report
13. Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis
14. Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits
15. Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E)
16. On the role of vitamin C and other antioxidants in atherogenesis and vascular dysfunction
17. Synthesis of a novel vitamin E derivative,2-(α-D-glucopyranosyl)methyl-2,5,7,8-tetramethylchroman-6- ol, by β-glucosidase-catalyzed transglycosylation
18. Antioxidant activity of a novel vitamin E derivative, 2-(α-D-glucopyranosyl)methyl-2,5,7,8-tetramethylchroman-6-ol
19. A novel water-soluble vitamin E derivative protects against experimental colitis in rats
20. Practical methods for plasma lipoprotein analysis
21. Inhibition of mammalian 15-lipoxygenase-dependent lipid peroxidation in low-density lipoprotein by quercetin and quercetin monoglucosides
22. Simple assay for the level of total lipid peroxides in serum or plasma
23. Antioxidant defenses and lipid peroxidation in human blood plasma
24. Antiatherogenic effects of the antioxidant BO-653 in three different animal models
25. Dissociation of atherogenesis from aortic accumulation of lipid hydroperoxides in Watanabe heritable hyperlipidemic rabbits
26. Soluble vascular cell adhesion molecule-1 (VCAM-1) as potential marker of atherosclerosis
27. Interleukin-8 and its receptor CXCR2 in atherosclerosis
28. Antioxidants inhibit the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells
29. Vitamin E protects against polymorphonuclear leukocyte-dependent adhesion to endothelial cells
30. Inhibitory effects of vitamin E on endothelial-dependent adhesive interactions with leukocytes induced by oxidized low density lipoprotein